IN IN149CHE2014A

TOPICAL TAZAROTENE SOLID LIPID NANOPARTICLES

Abstract

[0001] The present invention relates to a drug delivery system comprising solid lipid nanoparticles (SLNs) wherein the solid lipid nanoparticles comprise a therapeutically effective amount of Tazarotene or it pharmaceutically acceptable salts, one or more lipid(s) and surfactant(s) along with one or more pharmaceutically acceptable excipients. The present invention also relates to a pharmaceutical composition comprising this delivery system and a process for the preparation of such composition thereof.

Source documents

Does this actually block you?

A document turning up in a search is not the same as a document that anticipates your claims. Our registered Patent Agents read the claims, not just the abstract, and tell you where you still have room.

Protect Your Invention

Bibliographic data via the European Patent Office's Open Patent Services (DOCDB) . Republished here for research and prior-art review. This page is not legal advice, and its presence in our index says nothing about the validity or enforceability of the document. For the Indian legal position (status, oppositions, renewals), see InPASS.